Skip to main content
Market intelligence
MDGLHealthcare

Madrigal Pharmaceuticals Inc insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Jun 1, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jun 1, 2026David SoergelChief Medical OfficerSale1,042$495.74$516,561
May 22, 2026Richard S LevyCorporate insiderSale5,682$515.44$2,928,716
May 18, 2026David SoergelChief Medical OfficerSale844$515.90$435,420